000520.KS
Samil Pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,080.00
−0.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.03x
- Price / sales
- 0.62x
- Price / cash flow
- -4945.73x
Enterprise value
- Enterprise value
- KRW 299.1B
- EV / sales
- 1.44x
- EV / EBITDA
- -7.60x
- EV / EBIT
- -9.92x
- Market cap
- KRW 129.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026